Cargando…

Bacteriotherapy for inflammatory bowel disease

The number of patients with inflammatory bowel disease is rapidly increasing in developed countries. The main cause of this increase is thought not to be genetic, but secondary to rapidly modernized environmental change. Changes in the environment have been detrimental to enteric probiotics useful f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimatsu, Yusuke, Mikami, Yohei, Kanai, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807454/ https://www.ncbi.nlm.nih.gov/pubmed/33441186 http://dx.doi.org/10.1186/s41232-020-00153-4

Ejemplares similares

Bacteriotherapy
Publicado: (1887)

Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
por: Liu, Jun, et al.
Publicado: (2022)

Bacteriotherapy in Breast Cancer
por: Yaghoubi, Atieh, et al.
Publicado: (2019)

Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery
por: Iwata, Kentaro, et al.
Publicado: (2021)

Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases
por: Ito, Yoshihiro, et al.
Publicado: (2022)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
por: Aoki, Yasuhiro, et al.
Publicado: (2023)

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
por: Batoni, Giovanna, et al.
Publicado: (2022)

Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis
por: Dewi, Dian Andriani Ratna, et al.
Publicado: (2023)

Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Recent trends in diagnostic techniques for inflammatory bowel disease
por: Naganuma, Makoto, et al.
Publicado: (2015)

Video capsule endoscopy in inflammatory bowel disease
por: Limpias Kamiya, Kenji J.L., et al.
Publicado: (2021)

Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection()
por: Adamu, Blessing O, et al.
Publicado: (2013)

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer
por: Henderson, Emily A., et al.
Publicado: (2023)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022)

Oral bacteriotherapy in children with recurrent respiratory infections: a real-life study
por: Tarantino, Vincenzo, et al.
Publicado: (2020)

D-amino Acids Ameliorate Experimental Colitis and Cholangitis by Inhibiting Growth of Proteobacteria: Potential Therapeutic Role in Inflammatory Bowel Disease
por: Umeda, Satoko, et al.
Publicado: (2023)

Reviewing not Homer’s Iliad, but “Kai Bao Ben Cao”: indigo dye—the past, present, and future
por: Yoshimatsu, Yusuke, et al.
Publicado: (2023)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
por: Lawley, Trevor D., et al.
Publicado: (2012)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficile Infection
por: Zainah, Hadeel, et al.
Publicado: (2012)

Predictors of necessity for endoscopic balloon dilatation in patients with Crohn’s disease-related small bowel stenosis
por: Hayashi, Yukie, et al.
Publicado: (2021)

De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer’s Disease
por: Bonfili, Laura, et al.
Publicado: (2021)

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study
por: Svensson, Camilla Kara, et al.
Publicado: (2022)

Effectiveness and Durability of Ustekinumab Therapy With or Without Immunomodulators for Ulcerative Colitis Patients in Japan
por: Aoki, Yasuhiro, et al.
Publicado: (2022)

Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

The Bowel Microbiota and Inflammatory Bowel Diseases
por: Tannock, Gerald W.
Publicado: (2010)

Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology
por: Sunaga, Shogo, et al.
Publicado: (2022)

Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model
por: Ihekweazu, Faith D., et al.
Publicado: (2019)

Inflammatory Bowel Disease
por: Nasseri-Moghaddam, Siavosh
Publicado: (2012)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

Gut microbiota and its complex role. The experience of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş” in fecal bacteriotherapy for Clostridium difficile infection
por: Apostolescu, Cătălin, et al.
Publicado: (2013)

Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek, Martin, et al.
Publicado: (2021)

Neuroinflammation in inflammatory bowel disease
por: Lakhan, Shaheen E, et al.
Publicado: (2010)

Inflammatory Bowel Disease and Thrombosis
por: Tezel, Ahmet, et al.
Publicado: (2012)

Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ctpda9jd9obvplp87mldt3an6h